Age-specific changes in sex steroid biosynthesis and sex development

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 21, Issue 3, 2007, Pages 393-401

  Krone, Nils ^a   Hanley, Neil A ^b   Arlt, Wiebke ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

17alpha hydroxylase; 21 hydroxylase; androgen; bitpotent gonad; CAH; congenital adrenal hyperplasia; cortisol; CYP17A1; CYP21A2; dehydroepiandrosterone; DHEA; fetal adrenal; fetal gonad; P450 oxidoreductase; P450 oxidoreductase deficiency; POR; sex development; testosterone; urogenital ridge

Indexed keywords

ANDROGEN; ANDROSTANOLONE; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; CYTOCHROME P450; GLUCOCORTICOID; HYDROCORTISONE; MUELLERIAN INHIBITING FACTOR; OXIDOREDUCTASE; SEX HORMONE; STEROID 21 MONOOXYGENASE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

AGE; ANDROGEN SYNTHESIS; CONGENITAL ADRENAL HYPERPLASIA; EMBRYO; EMBRYONIC STRUCTURES; FEEDBACK SYSTEM; FETUS; FETUS (ANATOMY); FETUS DEVELOPMENT; GESTATION PERIOD; HORMONE SYNTHESIS; HUMAN; KARYOTYPE 46,XX; LEYDIG CELL; MALE GENITAL SYSTEM; MUELLERIAN DUCT; PATHOGENESIS; REVIEW; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION; SRY GENE; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS; TESTOSTERONE RELEASE; UPREGULATION; VIRILIZATION; Y CHROMOSOME;

ADRENAL HYPERPLASIA, CONGENITAL; AGING; ANIMALS; FEEDBACK, BIOCHEMICAL; FEMALE; GONADAL DYSGENESIS, 46,XX; GONADAL STEROID HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; PITUITARY-ADRENAL SYSTEM; SEXUAL DEVELOPMENT; STEROID 21-HYDROXYLASE;

EID: 34548571892     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2007.06.001     Document Type: Review

References (46)

1. Hanley N.A., Hagan D.M., Clement-Jones M., et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mechanisms of Development 91 (2000) 403-407
2. Parker K.L., and Schimmer B.P. Genes essential for early events in gonadal development. Annals of Medicine 34 (2002) 171-178
3. Wilhelm D., Palmer S., and Koopman P. Sex determination and gonadal development in mammals. Physiological Reviews 87 (2007) 1-28
4. Turnpenny L., Spalluto C.M., Perrett R.M., et al. Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells. Stem Cells 24 (2006) 212-220
5. Visser J.A. AMH signaling: from receptor to target gene. Molecular and Cellular Endocrinology 211 (2003) 65-73
6. MIM *600957. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=600957.
7. MIM *600956. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=600956.
8. MIM #261550. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=261550.
9. Josso N., Belville C., di Clemente N., et al. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Human Reproduction Update 11 (2005) 351-356
10. Sobel V., Zhu Y.S., and Imperato-McGinley J. Fetal hormones and sexual differentiation. Obstetrics and Gynecology Clinics of North America 31 (2004) 837-841
11. MIM *607306. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=607306.
12. Imperato-McGinley J., Guerrero L., Gautier T., et al. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186 (1974) 1213-1215
13. Imperato-McGinley J., and Zhu Y.S. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Molecular and Cellular Endocrinology 198 (2002) 51-59
14. Wilson J.D. Dihydrotestosterone formation in cultured human fibroblasts. Comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, Type 2. The Journal of Biological Chemistry 250 (1975) 3498-3504
15. MIM +152790. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=152790.
16. Themmen A.P.N., and Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 21 (2000) 551-583
17. Parker K.L., Rice D.A., Lala D.S., et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Progress in Hormone Research 57 (2002) 19-36
18. MIM +184757. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=184757.
19. Achermann J.C., Ito M., Ito M., et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genetics 22 (1999) 125-126
20. Lin L., Philibert P., Ferraz-de-Souza B., et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. The Journal of Clinical Endocrinology and Metabolism 92 (2007) 991-999
21. Siiteri P.K., and Wilson J.D. Testosterone formation and metabolism during male sexual differentiation in the human embryo. The Journal of Clinical Endocrinology and Metabolism 38 (1974) 113-125
22. Goto M., Piper H.K., Marcos J., et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. The Journal of Clinical Investigation 116 (2006) 953-960
23. Grumbach M.M., and Auchus R.J. Estrogen: consequences and implications of human mutations in synthesis and action. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 4677-4694
24. Shapiro E., Huang H.Y., and Wu X.R. Uroplakin and androgen receptor expression in the human fetal genital tract: insights into the development of the vagina. The Journal of Urology 164 (2000) 1048-1051
25. Hughes I.A., Houk C., Ahmed S.F., et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood 91 (2006) 554-563
26. Krone N., Dhir V., Ivison H.E., et al. Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clinical Endocrinology 66 (2007) 162-172
27. Merke D.P., and Bornstein S.R. Congenital adrenal hyperplasia. Lancet 365 (2005) 2125-2136
28. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 21 (2000) 245-291
29. MIM +201910. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=201910.
30. David M., and Forest M.G. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. The Journal of Pediatrics 105 (1984) 799-803
31. Nimkarn S., and New M.I. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nature Clinical Practice. Endocrinology & Metabolism 3 (2007) 405-413
32. MIM #202110. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=202110.
33. Kagimoto M., Winter J.S., Kagimoto K., et al. Structural characterization of normal and mutant human steroid 17alpha-hydroxylase genes: molecular basis of one example of combined 17alpha-hydroxylase/17,20 lyase deficiency. Molecular Endocrinology 2 (1988) 564-570
34. Auchus R.J. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinology and Metabolism Clinics of North America 30 (2001) 101-119
35. Peterson R.E., Imperato-McGinley J., Gautier T., et al. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. The New England Journal of Medicine 313 (1985) 1182-1191
36. Adachi M., Tachibana K., Asakura Y., et al. A male patient presenting with major clinical symptoms of glucocorticoid deficiency and skeletal dysplasia, showing a steroid pattern compatible with 17alpha-hydroxylase/17,20-lyase deficiency, but without obvious CYP17 gene mutations. Endocrine Journal 46 (1999) 285-292
37. Kelley R.I., Kratz L.E., Glaser R.L., et al. Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. American Journal of Medical Genetics 110 (2002) 95-102
38. Arlt W., Walker E.A., Draper N., et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363 (2004) 2128-2135
39. Fluck C.E., Tajima T., Pandey A.V., et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nature Genetics 36 (2004) 228-230
40. MIM #201750. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=201750.
41. Dhir V., Ivison H.E., Krone N., et al. Differential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P. Molecular Endocrinology (2007 May 15) [epub ahead of print]
42. MIM #207410. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?cmd=entry&id=207410.
43. Antley R., and Bixler D. Trapezoidocephaly, midfacial hypoplasia and cartilage abnormalities with multiple synostoses and skeletal fractures. Birth Defects Original Article Series 11 (1975) 397-401
44. Wilson J.D., Auchus R.J., Leihy M.W., et al. 5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate. Endocrinology 144 (2003) 575-580
45. Mahendroo M., Wilson J.D., Richardson J.A., et al. Steroid 5alpha-reductase 1 promotes 5alpha-androstane-3alpha,17beta-diol synthesis in immature mouse testes by two pathways. Molecular and Cellular Endocrinology 222 (2004) 113-120
46. Gupta M.K., Guryev O.L., and Auchus R.J. 5alpha-reduced C21 steroids are substrates for human cytochrome P450c17. Archives of Biochemistry and Biophysics 418 (2003) 151-160